Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 92 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $554,281 | -19.0% | 101,703 | +0.9% | 0.00% | 0.0% |
Q2 2023 | $684,452 | -9.4% | 100,803 | -33.2% | 0.00% | 0.0% |
Q1 2023 | $755,508 | +21.4% | 150,800 | +18.2% | 0.00% | 0.0% |
Q4 2022 | $622,483 | -43.8% | 127,558 | +66.1% | 0.00% | -50.0% |
Q3 2022 | $1,108,000 | -26.1% | 76,817 | -22.5% | 0.00% | 0.0% |
Q2 2022 | $1,499,000 | +37.0% | 99,094 | +7.6% | 0.00% | +100.0% |
Q1 2022 | $1,094,000 | +64.5% | 92,100 | +124.6% | 0.00% | +100.0% |
Q4 2021 | $665,000 | -43.2% | 41,000 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $1,170,000 | -15.6% | 41,000 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $1,386,000 | +11.8% | 41,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,240,000 | -48.7% | 41,000 | -16.0% | 0.00% | -50.0% |
Q4 2020 | $2,416,000 | +11.4% | 48,800 | -13.6% | 0.01% | +20.0% |
Q3 2020 | $2,169,000 | +1.8% | 56,500 | +14.6% | 0.01% | -16.7% |
Q2 2020 | $2,130,000 | +98.1% | 49,300 | +19.7% | 0.01% | +50.0% |
Q1 2020 | $1,075,000 | +12.4% | 41,200 | +34.6% | 0.00% | +100.0% |
Q4 2019 | $956,000 | +19.9% | 30,600 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $797,000 | +245.0% | 30,600 | +203.0% | 0.00% | +100.0% |
Q2 2019 | $231,000 | – | 10,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |